| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5544797 | Veterinary Immunology and Immunopathology | 2017 | 31 Pages |
Abstract
Results of these studies led to USDA conditional approval of commercially available recombinant vaccines for use in turkeys as a control measure for clade 2.3.4.4 H5 HPAI epizootics.
Keywords
NaDCQuantitative real time RT-PCRAPHISBPlHPAILPAISPFhighly pathogenic avian influenzaLow pathogenic avian influenzaHAUBeta-propiolactoneDIVAViral sheddingsubcutaneousReverse geneticsHemagglutinin inhibitionhemagglutininRecombinant vaccinehighly pathogenic avian influenza virusspecific pathogen freeVaccine efficacy
Related Topics
Life Sciences
Agricultural and Biological Sciences
Animal Science and Zoology
Authors
Darrell R. Kapczynski, Matthew J. Sylte, Mary L. Killian, Mia K. Torchetti, Klaudia Chrzastek, David L. Suarez,